Careers
Employee Login
Client Login
Pay My Bill
Order Products
Home
About
Overview
Corporate
Compliance
Diagnostics
Marketing
IT and Software
Medical Billing
Board of Directors
Solutions
Overview
Hospitals
Diagnostic Solutions
Revenue Cycle Management
Healthcare Technology Solutions
Financial Services
Brands
Overview
Medytox Diagnostics
Clinlab
Medical Mime
Medical Billing Choices
Advantage
CollabRX
Platinum Financial Solutions
Genomas
News & Media
Press Releases
Events
Blog
Presentations
Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Proxy Materials
Contact
Contact Us
Locations
All SEC Filings
Menu
Overview
News / Events
Press Releases
Pre-Merger News
IR Calendar
Email Alerts
Company Information
Profile
Presentations
Management Team
Contacts
FAQ
Financial Information
Financials
Financial Results
Stock Data
Quote
Warrant Data
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Proxy Materials
Proxy Materials
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Filter Filings:
View All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
25-NSE
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
5
8-A12B
8-K
8-K/A
AW
CERTNAS
CORRESP
D
DEF 14A
DEF 14C
DEFA14A
DEFR14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
PRE 14C
PREM14A
PRER14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-2
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
02/14/96
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
6
<< Previous
1...
102
103
104
105
106
107
108
109
110
111
